EPISODE · May 17, 2021 · 25 MIN
3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe
from Plenary Session - inactive due to federal service · host Plenary Session
Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases. Race Reporting: doi.org/10.1038/s41391-021-00361-0 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
What this episode covers
Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases. Race Reporting: doi.org/10.1038/s41391-021-00361-0 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
NOW PLAYING
3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.